Veritas Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 1338.39%
- Profit Growth 361.19%
- Ebitda 1661.18%
- Net Worth 96.21%
- Total Assets 198.39%
About Veritas Laboratories
Veritas Laboratories Private Limited (VLPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 June 2016 (Eight years and seven months 24 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Niraj Chandak and Pareshwar Joshi serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909DL2016PTC301118
-
Company No.
301118
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Jun 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Veritas Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Niraj Chandak
|
Director | 04-Oct-2022 | Current |
|
Pareshwar Joshi
|
Director | 24-Apr-2024 | Current |
Financial Performance of Veritas Laboratories.
Veritas Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1338.39% increase. The company also saw a substantial improvement in profitability, with a 361.19% increase in profit. The company's net worth Soared by an impressive increase of 96.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Veritas Laboratories?
Unlock access to Veritas Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Svan Chemicals Private LimitedNiraj Chandak is a mutual person
-
Livia Lifesciences Private Limited
Niraj Chandak is a mutual person
-
Enco Speciality Chemicals Private Limited
Niraj Chandak is a mutual person
-
Oak Fine Chemicals Private Limited
Niraj Chandak is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Veritas Laboratories?
Unlock and access historical data on people associated with Veritas Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Veritas Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Veritas Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
